FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for VALSARTAN submitted by Macleods Pharmaceuticals Limited, indicating approval of changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Post-myocardial Infarction Left Ventricular Dysfunction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)